Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Inventory (2016 - 2026)

Orthofix Medical has reported Inventory over the past 17 years, most recently at $177.8 million for Q1 2026.

  • For the quarter ending Q1 2026, Inventory rose 1.91% year-over-year to $177.8 million, compared with a TTM value of $177.8 million through Mar 2026, up 1.91%, and an annual FY2025 reading of $172.3 million, down 9.04% over the prior year.
  • Inventory came in at $177.8 million for Q1 2026, up from $172.3 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $222.5 million in Q2 2023 to a low of $88.8 million in Q1 2022.
  • Median Inventory over the past 5 years was $177.8 million (2026), compared with a mean of $174.8 million.
  • The sharpest move saw Inventory skyrocketed 149.83% in 2023, then fell 20.36% in 2025.
  • Over 5 years, Inventory stood at $100.1 million in 2022, then surged by 121.83% to $222.2 million in 2023, then dropped by 14.73% to $189.5 million in 2024, then decreased by 9.04% to $172.3 million in 2025, then increased by 3.19% to $177.8 million in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Inventory are $177.8 million (Q1 2026), $172.3 million (Q4 2025), and $174.0 million (Q3 2025).